Harrow Health (NASDAQ:HROW – Get Rating) had its price target upped by Lake Street Capital from $24.00 to $37.00 in a research report report published on Monday, The Fly reports. Lake Street Capital currently has a buy rating on the stock. Several other analysts have also recently weighed in on the company. B. Riley lifted […]